期刊文献+

OOS的统计判定策略及国内常见问题探讨 被引量:7

Discussion on the statistical decision strategy of out-of-specification(OOS) and the common problems in China
原文传递
导出
摘要 对产品是否为不合格项(OOS)的准确判定,特别是对其测量属性接近其质量限的边缘产品的判定,是非常具有挑战性的问题。它不仅是质量控制中不可或缺的内容,更是检测实验室的能力体现。本文结合国际上合格性判定的相关法规和指导原则,从统计的不确定度和风险评估等角度,探讨了判断边缘产品是否属于OOS的几个基本前提要素,分析了目前国内在边缘产品的OOS判定中存在的常见问题,并用实例系统地阐述了相关判定策略,以期为今后OOS的科学判定提供依据。 Accurate determination is a particularly challenging issue whether a product is an OOS or not,especially when it is an edge product which the measurand is close to the specification limit. It is not only an indispensable part in quality control system,but also an indicator showing the ability of the testing laboratory. Based on the relevant regulations and guiding principles of international conformance decision,this paper discusses the premise elements to judge whether edge products belong to OOS or not from the perspectives of statistical(measurement uncertainty) and risk assessment,the common problems existing in the OOS decision of edge products in China,and also the systematically expounds the relevant decision strategies with examples,so as to provide the basis for the scientific decision of OOS in the future.
作者 李娜 马莉 谭德讲 许卉 LI Na;MA Li;TAN De-jiang;XU Hui(National Institutes for Food and Drug Control,Beijing 102629,China;Yantai University,Yantai 264003,China)
出处 《药物分析杂志》 CAS CSCD 北大核心 2019年第10期1915-1920,共6页 Chinese Journal of Pharmaceutical Analysis
基金 北京市科技计划课题资助项目(Z151100000115013)
关键词 不合格项(OOS) 质量限 警戒区间 测量不确定度 严格接受标准 宽松接受标准 决策规则 out-of-specification(OOS) specification limit guard band measurement uncertainty stringent acceptance standard relaxed acceptance standard decision rule
  • 相关文献

参考文献5

二级参考文献25

  • 1陶靖轩.关于过程能力指数和不合格品率之间的关系研究[J].中国计量学院学报,2012,23(3):315-318. 被引量:3
  • 2王斌会,胡志萍.过程能力指数与不合格品率的关系模型[J].数理统计与管理,2007,26(1):57-61. 被引量:10
  • 3Koppel H,Schneider B,Watzig H.Out-of-specification Test Results from the Statistical Point of View[J].Journal of Pharmaceutical and Biomedical Analysis,2007,44:718-829.
  • 4CDER,FDA,DHHS.Draft Guidance for Industry:Investigating out of Specification(OOS)Test Results for Pharmaceutical Production.Bethesda Md[S].1998.
  • 5US FDA(2006)Guidance for Industry.Investigating Outof-specification(OOS)Test Results for Pharmaceutical Production[S].2006.
  • 6Brian K.Nunnally,PhD.Deedra F.Nunnally,John S.McConnell.Avoiding the Pain of Out-of-Specification Results(Failing to Apply Iimportant Statistical Principles Ieads to Unnecessary Investigations and Wastes Time and Rresources.Control Charts Can Help) [EB/OL].[2015-03-11].Biopharm International,1 Jun 2008,21 ( 6 ) :http://www.biopharminternational.com/biopharm/article/articleDetail.jsp?id=522197.
  • 7Tim Sandle.Investigating Sterility Test Failures.Global BioPharmaceutical Resources,Inc.February 2011 GBPR,Inc.Newsletter[S].2011.
  • 8Jenny Hantzinikolas.Laboratory Investigations-A Regulatory Perspective[S].29 July 2008.
  • 9European Compliance Academy.OOS Forum[S].28 August,2014.
  • 10Ilya Kuselman,Francesca Pennecchi,Cathy Burns,et al.Investigating Out-of-Specification Test Results of Chemical Composition Based on Metrological Concepts[J].Accred Qual Assur,2010,15:283-288.

共引文献28

同被引文献42

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部